Does FLUOROPHARMA MEDICAL INC COMMON SHARES (OTCMKTS:FPMI) Have Gas After Even More Sellers Involved?

April 6, 2018 - By simple simple

FluoroPharma Medical, Inc. (OTCMKTS:FPMI) Logo

The stock of FLUOROPHARMA MEDICAL INC COMMON SHARES (OTCMKTS:FPMI) registered an increase of 35.29% in short interest. FPMI’s total short interest was 2,300 shares in April as published by FINRA. Its up 35.29% from 1,700 shares, reported previously. The short interest to FLUOROPHARMA MEDICAL INC COMMON SHARES’s float is 0.01%.

It closed at $0.07 lastly. It is down 0.00% since April 6, 2017 and is . It has underperformed by 11.55% the S&P500.

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. The company has market cap of $2.41 million. The Company’s product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease ; and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. It currently has negative earnings. The firm has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.